Barclays Begins Coverage on BKV (NYSE:BKV)

Equities researchers at Barclays assumed coverage on shares of BKV (NYSE:BKV) in a research report issued to clients and investors on Thursday, Marketbeat reports. The brokerage set an “overweight” rating and a $32.00 price target on the stock. Barclays‘s price objective points to a potential upside of 14.60% from the stock’s previous close.

Several other brokerages have also recently weighed in on BKV. Susquehanna upped their price target on BKV from $32.00 to $33.00 and gave the stock a “positive” rating in a research note on Tuesday. Mizuho upped their target price on shares of BKV from $30.00 to $33.00 and gave the stock an “outperform” rating in a research report on Thursday, October 30th. KeyCorp increased their price target on shares of BKV from $25.00 to $30.00 and gave the stock an “overweight” rating in a research note on Tuesday. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of BKV in a research note on Wednesday, October 8th. Six research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $30.67.

BKV Price Performance

Shares of NYSE BKV opened at $27.92 on Thursday. BKV has a 1 year low of $15.00 and a 1 year high of $28.15. The stock has a market capitalization of $2.51 billion, a P/E ratio of 53.70 and a beta of 1.70. The company’s 50-day moving average is $22.84 and its 200 day moving average is $22.16. The company has a debt-to-equity ratio of 0.27, a current ratio of 0.85 and a quick ratio of 0.52.

BKV (NYSE:BKV) last posted its quarterly earnings data on Monday, November 10th. The company reported $0.50 earnings per share for the quarter, beating the consensus estimate of $0.16 by $0.34. BKV had a return on equity of 6.91% and a net margin of 5.67%.The business had revenue of $199.23 million for the quarter, compared to analysts’ expectations of $234.36 million. On average, sell-side analysts expect that BKV will post -1.82 earnings per share for the current year.

Insider Transactions at BKV

In related news, insider Lindsay B. Larrick sold 22,669 shares of the company’s stock in a transaction dated Wednesday, November 5th. The shares were sold at an average price of $25.00, for a total value of $566,725.00. Following the transaction, the insider owned 143,672 shares in the company, valued at $3,591,800. The trade was a 13.63% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In the last quarter, insiders have sold 54,187 shares of company stock valued at $1,311,375. Insiders own 4.11% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. Quantbot Technologies LP purchased a new stake in shares of BKV during the first quarter valued at approximately $1,605,000. Bank of New York Mellon Corp lifted its position in BKV by 21.2% in the 1st quarter. Bank of New York Mellon Corp now owns 35,453 shares of the company’s stock valued at $745,000 after acquiring an additional 6,209 shares in the last quarter. Cooper Creek Partners Management LLC boosted its stake in BKV by 35.6% during the 3rd quarter. Cooper Creek Partners Management LLC now owns 461,657 shares of the company’s stock valued at $10,678,000 after purchasing an additional 121,082 shares during the last quarter. Strs Ohio bought a new stake in shares of BKV in the 3rd quarter worth $278,000. Finally, Geode Capital Management LLC raised its stake in shares of BKV by 13.9% in the second quarter. Geode Capital Management LLC now owns 376,232 shares of the company’s stock worth $9,076,000 after purchasing an additional 45,989 shares during the last quarter.

About BKV

BKV Corporation engages in the acquisition, operation, and development of natural gas and NGL properties. It is also involved in the gathering, processing, and transportation of natural gas. The company was founded in 2015 and is based in Denver, Colorado with additional offices in Tunkhannock, Pennsylvania and Fort Worth, Texas.